{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-102129","form_type":"8-K","ticker":"BTMD","cik":"0001819253","company_name":"biote Corp.","filed_at":"2026-03-11T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.322031+00:00","generated_at":"2026-05-15T14:59:21.090973+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Biote Q4 revenue $46.4M; net income $2.6M; anticipates procedure growth H2 2026","bullets":["Q4 2025 revenue $46.4M, gross margin 68.0%; net income $2.6M ($0.06 diluted EPS), down from $3.5M ($0.10) in Q4 2024.","Full year 2025 revenue $192.2M; net income $31.6M ($0.74 diluted EPS), versus $0.05M ($0.09) in 2024.","Adjusted EBITDA Q4 $11.7M (25.2% margin); full year adjusted EBITDA $53.5M (27.8% margin).","CEO Bret Christensen anticipates return to procedure revenue growth in second half of 2026.","Company rebuilding commercial sales coverage; commercial transition impacted 2025 results as expected."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-102129","json":"https://secwatch.observer/filing/0001193125-26-102129.json","markdown":"https://secwatch.observer/filing/0001193125-26-102129.md","text":"https://secwatch.observer/filing/0001193125-26-102129.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1819253/000119312526102129/0001193125-26-102129-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1819253/000119312526102129/btmd-20260311.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T14:59:21.090973+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"164c29d5c5d6a8240b6a38059ba43f320dc7978e","claim":"biote Corp. reported Full Year 2025 results: revenue $192.2 million, net income $31.6 million, EPS $0.74 per diluted share.","evidence_excerpt":"Full Year 2025 Financial Highlights • Revenue of $192.2 million • Gross profit margin of 71.5% • Net income of $31.6 million and diluted earnings per share attributable to biote Corp. stockholders of $0.74 per diluted share, compared to net income of $0.05 million and diluted earnings per share attributable to biote Corp. stockholders of $0.09 in 2024","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1819253/000119312526102129/0001193125-26-102129-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"Full Year 2025"},{"label":"Revenue","value":"$192.2 million"},{"label":"Net income","value":"$31.6 million"},{"label":"EPS","value":"$0.74 per diluted share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"ec467c347580f67b6f20997eb542b4ed1cd57e6a","claim":"biote Corp. reported the fourth quarter and fiscal year ended December 31, 2025 results: revenue $46.4 million, net income $2.6 million, EPS $0.06.","evidence_excerpt":"expansion to capture large growth opportunity Anticipate a return to procedure revenue growth in the second half of 2026 Fourth Quarter 2025 Financial Highlights • Revenue of $46.4 million • Gross profit margin of 68.0% • Net income of $2.6 million and diluted earnings per share attributable to biote Corp. stockholders of $0.06, compared to net income of $3.5","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1819253/000119312526102129/0001193125-26-102129-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fourth quarter and fiscal year ended December 31, 2025"},{"label":"Revenue","value":"$46.4 million"},{"label":"Net income","value":"$2.6 million"},{"label":"EPS","value":"$0.06"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}